Kenvue shares fall even as J&J spinoff beats estimates in first quarterly earnings since IPO

J&J still owns a 90% stake in Kenvue, meaning it can generally control the direction of the consumer health spinoff’s business for the time being.  » Read More

- A word from our sposor -

spot_img